Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-25-000003
Filing Date
2025-01-02
Accepted
2025-01-02 20:40:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7692
  Complete submission text file 0001535610-25-000003.txt   9473
Mailing Address 7012 FISHER ISLAND DR MIAMI BEACH FL 33109
Business Address 7012 FISHER ISLAND DR MIAMI BEACH FL 33109 646-307-4500
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Subject) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91762 | Film No.: 25503583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)